HealthCare Global Enterprises: Board ne **₹425 Cr** Rights Issue approve kiya, Investors ki kya hai duty?

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorAnanya Iyer|Published at:
HealthCare Global Enterprises: Board ne **₹425 Cr** Rights Issue approve kiya, Investors ki kya hai duty?
Overview

Arre suno! HealthCare Global Enterprises (HCG) ne apne investors ke liye ek bada announcement kiya hai. Board ne **₹425 crore** ka rights issue approve kar diya hai, jismein har **17 share** ke liye **1 naya share** milega, aur price rakha gaya hai **₹512** per share. Record date hai **March 2, 2026**.

HCG ka Fund Raise Plan Explained!

HealthCare Global Enterprises (HCG) apni balance sheet ko aur mazboot karne aur growth plans ko support karne ke liye yeh paisa raise kar raha hai. Company ne pichle kuch saalon mein kaafi expansion kiya hai, jiske liye ₹800-900 crore ka capital expenditure hua hai. Is wajah se company ka total debt FY25 tak badhkar ₹1,837.22 crore ho gaya tha.

Rights Issue: Shareholders ke liye kya hai?

Is rights issue mein, jo current shareholders hain unko company ke naye shares kharidne ka mauka milega. Har 17 existing equity shares par 1 naya equity share milne wala hai. Issue price ₹512 per share rakha gaya hai. Isse company ko fresh capital milega bina naya debt liye, aur shareholders apna stake badha sakte hain.

KKR ka Entry aur Aage ka Plan

Abhi haal hi mein, KKR ne CVC se HCG mein majority stake acquire kiya hai. Is deal ke baad, company ne ₹150 crore tak ka investment bhi apni subsidiaries mein karne ka plan banaya hai working capital aur dues clear karne ke liye.

Kya Badlega?

Jab yeh rights issue successfully subscribe ho jayega, toh HCG ke total outstanding equity shares 14.1 crore se badhkar lagbhag 14.9 crore ho sakte hain. Isse company ki financial flexibility badhegi aur growth initiatives ko support milega.

Dhyan Rakhne Wali Baatein

  • Rights issue period ko extend bhi kiya ja sakta hai.
  • Agar aapne rights entitlement par apply nahi kiya toh woh lapse ho jayenge.
  • Company par abhi bhi debt kaafi hai, debt-to-equity ratio FY25 mein 177.9% tha.

Investors ke liye Track karne wali cheezein

Ab investors ko SEBI se aane wale approval ka intezar karna hoga, aur fir rights issue mein subscription levels dekhne honge. Yeh bhi dekhna hoga ki company is raise kiye hue paison ko kaise use karti hai aur KKR ke aane se company ke strategy mein kya changes aate hain.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.